# Phio Pharmaceuticals Corp.: Form 8-K, filed Sep 15, 2017

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2017-09-15
- Accepted by EDGAR: Sep 15, 2017, 16:30 ET
- Period: 2017-09-15
- Accession: 0001193125-17-286393
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000119312517286393/d446207d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000119312517286393/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000119312517286393/d446207d8k.htm

Filed Sep 15, 2017.
Source: SEC EDGAR, the filing index for accession 0001193125-17-286393. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
